1
|
Mphasha MH, Mothiba TM, Skaal L. Daily living activities' performance by male diabetics with sexual dysfunction in South Africa. Afr J Prim Health Care Fam Med 2023; 15:e1-e6. [PMID: 37526558 PMCID: PMC10476452 DOI: 10.4102/phcfm.v15i1.3885] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2022] [Revised: 12/11/2022] [Accepted: 01/11/2023] [Indexed: 08/02/2023] Open
Abstract
BACKGROUND Sexual dysfunction (SD) is a common complication among men living with diabetes (MLWD), which adds to stresses induced by medical condition. Effect of stress on their daily living activities has been only poorly described. AIM This study aimed to explore the behaviour and challenges of MLWD experiencing SD in respect of daily living activities. SETTING Five clinics in Senwabarwana in Limpopo province. METHODS Qualitative approach and phenomenological exploratory design were adopted to collect data from 15 male participants selected from five clinics using purposive homogeneous sampling. One-on-one interviews were conducted using voice recorders, and field notes were taken of non-verbal cues. Unstructured interview guide with principal question enabled instructive probing to be conducted. Data were analysed using eight steps of Tesch's inductive, descriptive and open coding technique. RESULTS Participants reported stressful experiences, difficulty coping with diabetes and its accompanying complication of SD that led to fear of losing their wives. They indicated that as a result of stress and difficulty in coping with the condition, they were engaged in less physical activity than before their diagnosis. CONCLUSION Sexual dysfunction is prevalent among male diabetics and often feel stressed and worried about losing their wives. They struggle to cope with conditions to the point where they are less capable of performing tasks than they were before diagnosis. These outcomes are critical issues that should be addressed in any diabetes treatment strategy.Contribution: Support-based collaboration of healthcare providers with spouses and revision of South African diabetes management strategy to incorporate healthy coping strategies are recommended.
Collapse
Affiliation(s)
- Mabitsela H Mphasha
- Department of Public Health, Faculty of Healthcare Sciences, University of Limpopo, Polokwane.
| | | | | |
Collapse
|
2
|
Hu WS, Lin CL. Using progression in adapted diabetes complications severity index score to predict erectile dysfunction in men affected by type 2 diabetes mellitus. Postgrad Med J 2023; 99:566-569. [PMID: 37319150 DOI: 10.1136/postgradmedj-2022-141557] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2022] [Accepted: 04/03/2022] [Indexed: 12/14/2022]
Abstract
OBJECTIVE This study is on the use of the adapted Diabetes Complications Severity Index (aDCSI) for erectile dysfunction (ED) risk stratification in male patients with type 2 diabetes mellitus (DM). METHODS This is a retrospective study with records obtained from Taiwan's National Health Insurance Research Database. Adjusted HRs (aHRs) were estimated by multivariate Cox proportional hazards models with 95% confidence intervals (CIs).. RESULTS A population of 84 288 eligible male patients with type 2 DM were included. Compared with change in aDCSI score of 0.0-0.5 per year, the aHRs and the corresponding 95% CIs for other changes in aDCSI scores are summarised as follows: 1.10 (0.90 to 1.34) for change in aDCSI score of 0.5-1.0 per year; 4.44 (3.47 to 5.69) for change in aDCSI score of 1.0-2.0 per year; and 10.9 (7.47 to 15.9) for change in aDCSI score of >2.0 per year.. CONCLUSIONS Progression in aDCSI score might be used for ED risk stratification in men affected by type 2 DM.
Collapse
Affiliation(s)
- Wei Syun Hu
- School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
- Division of Cardiovascular Medicine, Department of Medicine, China Medical University Hospital, Taichung, Taiwan
| | - Cheng Li Lin
- School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan
| |
Collapse
|
3
|
Obaid ZM, Amer AW, Zaky MS, Elhenawy RM, Megahed AEM, Hanafy NS, Elsaie ML. Prevalence of female sexual dysfunction among diabetic females: a cross sectional case controlled study. Postgrad Med 2022; 134:680-685. [PMID: 35838136 DOI: 10.1080/00325481.2022.2102842] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
BACKGROUND Sexual relationships, sexual functions are all parts of the female sexual identity and which influence physiological, psychological and reproductive functions of women. AIM OF THE WORK The study aimed to identify prevalence of Female Sexual Dysfunction (FSD) in women affected by type 1 and type 2 Diabetes Mellitus (DM) and to evaluate the impact of diabetes on female sexuality. PATIENT AND METHODS This cross-sectional study was carried out on 400 married females who were interviewed to answer Female Sexual Function Index (FSFI) questionnaire and were divided into two groups: the first group included 300 diabetes patients (134 patients with type 1 DM and 166 patients with type 2 DM), while the second included 100 women not diagnosed with diabetes who served as controls. RESULTS Considering female sexual dysfunction (score < 26.55), there was statistically significant increase of patients with female sexual dysfunction (FSD) in Type1 DM (50.7%) when compared to type 2 DM patients (28.9%) or control group (10.0%).. Conclusion FSD is a significant health problem in premenopausal women complaining of DM. Females with type 1 DM were more affected than females with type 2 DM, who in turn were more affected than healthy controls. Long duration of the disease was the main risk factor for developing FSD.
Collapse
Affiliation(s)
- Zakaria M Obaid
- Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Egypt
| | - Ahmed W Amer
- Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Egypt
| | - Mohamed S Zaky
- Department of Dermatology, Venereology and Andrology, Damietta Faculty of Medicine, Al-Azhar University, Egypt
| | - Raghda M Elhenawy
- Department of Dermatology, Damietta dermatology and leprosy hospital, Egypt
| | - Alaa Eldin M Megahed
- Department of Obstetrics and Gynaecology, Damietta Faculty of Medicine, Al-Azhar University, Egypt
| | - Noha S Hanafy
- Department of Dermatology, Medical Research and Clinical Studies Institute; National Research Centre, Egypt
| | - Mohamed L Elsaie
- Department of Dermatology, Medical Research and Clinical Studies Institute; National Research Centre, Egypt
| |
Collapse
|
4
|
García-Gómez B, Alonso-Isa M, Celada-Luis G, Jauregibeitia-Ansotegi I, García-Rojo E, Santos-Pérez de la Blanca R, Romero-Otero J. Analysis of the relationship between sexual satisfaction, erectile dysfunction, and penile vascular parameters in a cohort of patients. Transl Androl Urol 2022; 10:4313-4319. [PMID: 35070813 PMCID: PMC8749074 DOI: 10.21037/tau-21-792] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/08/2021] [Accepted: 12/06/2021] [Indexed: 11/06/2022] Open
Abstract
Background Erectile dysfunction (ED) is the second sexual dysfunction affecting men. Penile duplex ultrasound (PDU) with intracavernous injection of a vasoactive agent as alprostadil or papaverine, may play an important role in differentiating psychogenic from vasculogenic ED (arterial or venooclusive) and may also have an important role in the secondary prevention of cardiovascular events. The aim of this study is to investigate the relationship between the vascular parameters and sexual satisfaction as established by a questionnaire. Methods Prospective, multicenter analysis of all patients who underwent a PDU between September 2018 and April 2021 in four centers, including patients who were >18 years old and underwent a PDU for ED, Peyronie's disease (PD) or other reasons, signed informed consent and completed an adapted version of the Brief Sexual Symptom Checklist (BSSC). All the patients underwent a standard technique, and from a total of 325 patients, 16 were excluded because of low testosterone levels, and 15 due to missing data. Results A total of 294 patients were included for the analysis. Significant differences were found between patients with and without ED defined by their score in the Sexual Health Inventory for Men (SHIM) questionnaire in the PSV at 10', adjusted for age (38.07 vs. 44.95 cm/s; P=0.016), and in the PSV and the EHS at 10' for sexually satisfied and non-satisfied patients, and a significant correlation with those parameters and the probability of being sexually satisfied (r=0.147, P=0.011; r=0.132, P=0.023; respectively). Conclusions In our clinical practice we used the cut-off of >35 cm/s, that seems to be quite low looking at our results. The 10' measurement may be more sensitive in order to establish a diagnosis. BSSC questionnaire is a simple, easy-to perform tool to screen those patients at risk of developing sexual dysfunctions.
Collapse
Affiliation(s)
- Borja García-Gómez
- Urology Department, Hospital Universitario HM Montepríncipe, Boadilla del Monte, Spain.,ROC Clinic, Madrid, Spain
| | - Manuel Alonso-Isa
- ROC Clinic, Madrid, Spain.,Urology Department, Hospital Universitario HM Puerta del Sur, Móstoles, Spain
| | | | | | - Esther García-Rojo
- Urology Department, Hospital Universitario HM Montepríncipe, Boadilla del Monte, Spain
| | | | - Javier Romero-Otero
- Urology Department, Hospital Universitario HM Montepríncipe, Boadilla del Monte, Spain.,ROC Clinic, Madrid, Spain.,Urology Department, Hospital Universitario HM Puerta del Sur, Móstoles, Spain.,Urology Department, Hospital Universitario HM Sanchinarro, Madrid, Spain
| |
Collapse
|
5
|
Suijker CA, van Mazijk C, Keijzer FA, Meijer B. Phenomenological and existential contributions to the study of erectile dysfunction. MEDICINE, HEALTH CARE, AND PHILOSOPHY 2021; 24:597-608. [PMID: 34106416 PMCID: PMC8557142 DOI: 10.1007/s11019-021-10029-0] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Accepted: 06/03/2021] [Indexed: 06/12/2023]
Abstract
The current medical approach to erectile dysfunction (ED) consists of physiological, psychological and social components. This paper proposes an additional framework for thinking about ED based on phenomenology, by focusing on the theory of sexual projection. This framework will be complementary to the current medical approach to ED. Our phenomenological analysis of ED provides philosophical depth and illuminates overlooked aspects in the study of ED. Mainly by appealing to Merleau-Ponty's Phenomenology of Perception, we suggest considering an additional etiology of ED in terms of a weakening of a function of sexual projection. We argue that sexual projection can be problematized through cognitive interferences, changes in the 'intentional arc', and modifications in the subject's 'body schema'. Our approach further highlights the importance of considering the 'existential situation' of patients with ED. We close by reflecting briefly on some of the implications of this phenomenological framework for diagnosis and treatment of ED.
Collapse
Affiliation(s)
- Chris A Suijker
- Department of Urology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
- Faculty of Philosophy, University of Groningen, Groningen, The Netherlands.
| | - Corijn van Mazijk
- Faculty of Philosophy, University of Groningen, Groningen, The Netherlands
| | - Fred A Keijzer
- Faculty of Philosophy, University of Groningen, Groningen, The Netherlands
| | - Boaz Meijer
- Department of Urology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
| |
Collapse
|
6
|
Li X, Yang HF, Chen Y, Pei LJ, Jiang R. Effect of the icariin on endothelial microparticles, endothelial progenitor cells, platelets, and erectile function in spontaneously hypertensive rats. Andrology 2021; 10:576-584. [PMID: 34779135 DOI: 10.1111/andr.13127] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Revised: 10/19/2021] [Accepted: 11/03/2021] [Indexed: 12/15/2022]
Abstract
OBJECTIVES To investigate the effect of icariin on endothelial microparticles, endothelial progenitor cells, platelets, and erectile function in spontaneously hypertensive rats. MATERIALS AND METHODS Twelve 8-week-old healthy male Wistar-Kyoto rats and 12 spontaneously hypertensive rats were randomly divided into four following groups: Wistar-Kyoto control group (normal saline 1 ml/d given by gavage), Wistar-Kyoto + icariin group (icariin 10 mg/kg × d dissolved in 1 ml normal saline and given by gavage), spontaneously hypertensive rats control group (normal saline 1 ml/d given by gavage), and spontaneously hypertensive rats + icariin group (icariin 10 mg/kg × d dissolved in 1 ml normal saline and given by gavage). Four weeks later, the maximum intracavernous pressure/mean arterial pressure, platelet count, mean platelet volume, platelet distribution width, endothelial microparticles, endothelial progenitor cells, and vitronectin receptor were measured in each group. RESULTS Under 3 or 5 V electrical stimulation, the maximum intracavernous pressure/mean arterial pressure in the spontaneously hypertensive rats + icariin group (0.23 ± 0.03, 0.38 ± 0.02) was significantly higher compared to the spontaneously hypertensive rats control group (0.12 ± 0.02, 0.20 ± 0.02) (p<0.05). Platelet count, mean platelet volume, and platelet distribution width in the spontaneously hypertensive rats + icariin group (1103.67 ± 107.70 × 109 /L, 9.08 ± 0.50 fl, 11.87 ± 0.45%) were significantly lower than those in the spontaneously hypertensive rats control group (1298.00 ± 89.54 × 109 /L, 9.72 ± 0.44 fl, 13.03 ± 0.59%) (all p < 0.05). Endothelial microparticles, endothelial progenitor cells, and vitronectin receptor in the spontaneously hypertensive rats + icariin group (1.01 ± 0.28%, 1.53 ± 0.65%, 2.13 ± 0.53%) were significantly lower than those in the spontaneously hypertensive rats control group (1.58 ± 0.19%, 2.71 ± 0.64%, 3.76 ± 0.52%) (all p < 0.05). Moreover, maximum intracavernous pressure/mean arterial pressure was strongly negatively correlated with platelet distribution width and vitronectin receptor (r > 0.7), and maximum intracavernous pressure/mean arterial pressure was moderately negatively correlated with mean platelet volume, endothelial microparticles, and endothelial progenitor cells (0.5 < r<0.7). CONCLUSION Icariin may improve erectile function in spontaneously hypertensive rats by reducing the content of endothelial microparticles in blood and inhibiting the activation of the platelets. Endothelial microparticles, endothelial progenitor cells, and platelet activation-related (mean platelet volume, platelet distribution width, and vitronectin receptor) can be used as indicators for icariin to improve erectile function in spontaneously hypertensive rats.
Collapse
Affiliation(s)
- Xu Li
- Department of Urology, the Affiliated Hospital of Southwest Medical University, Luzhou, China
| | - Hai-Fan Yang
- Department of Urology, the Affiliated Hospital of Southwest Medical University, Luzhou, China
| | - Yong Chen
- Department of Urology, the Affiliated Hospital of Southwest Medical University, Luzhou, China
| | - Li-Jun Pei
- Department of Urology, the Affiliated Hospital of Southwest Medical University, Luzhou, China
| | - Rui Jiang
- Department of Urology, the Affiliated Hospital of Southwest Medical University, Luzhou, China
| |
Collapse
|
7
|
Elnaser Mohamed TA, Kamel II, Abdelaal AMA, Mohammad AF, GamalEl Din SF. Study of the risk factors of erectile dysfunction and phospho diestrase type 5 inhibitors usage among Egyptian population with erectile dysfunction: A cross-sectional survey. Rev Int Androl 2021; 19:249-258. [PMID: 33773939 DOI: 10.1016/j.androl.2020.05.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/04/2019] [Revised: 04/05/2020] [Accepted: 05/02/2020] [Indexed: 10/21/2022]
Abstract
OBJECTIVES We aimed to study the risk factors of erectile dysfunction (ED) and different patterns of phosphodiestrase type 5 inhibitors (PDE5is) usage among Egyptian patients. PATIENTS AND METHODS One thousand five hundred consecutive Egyptian patients complaining of ED were included in this cross-sectional study from July (2014) to October (2015). Patients were requested to answer the international index of erectile function questionnaire (IIEF-5). Statistical differences between groups were tested using Chi square test and Spearman's rho correlation coefficient for qualitative variables. RESULTS Remarkably, significant associations between IIEF scores and aging and diabetes mellitus (DM) and hypertension (HTN) and ischaemic heart disease (IHD) and hyperlipidaemia were shown in the studied patients (p<.0001, p<.0001, p<.0001, p<.0001, p<.0001, respectively). Eventually, our study showed significant correlations between different age groups and morning erection and lower urinary tract symptoms and HTN and IHD and DM where the severity of ED was directly proportional to the absence or decreased strength of morning erection with aging and the increased incidence of LUTS and HTN and IHD and DM with aging (p<.0001; p=.001; p<.0001; p<.0001; p<.0001, respectively). CONCLUSION Our study demonstrated that aging; DM, HTN and hyperlipidaemia are potential major risk factors of ED in Egypt for further validation. In addition, most of the participants used PDE5is without prior medical consultation together with concomitant administration of illicit drugs.
Collapse
Affiliation(s)
| | - Ihab Ismail Kamel
- Andrology & STDs Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt
| | | | | | - Sameh Fayek GamalEl Din
- Andrology & STDs Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.
| |
Collapse
|
8
|
Geerkens MJ, Al-Itejawi HH, Nieuwenhuijzen JA, Meuleman EJ, Lissenberg-Witte BI, van Moorselaar R, Vis AN. Sexual Dysfunction and Bother Due to Erectile Dysfunction in the Healthy Elderly Male Population: Prevalence from a Systematic Review. Eur Urol Focus 2020; 6:776-790. [DOI: 10.1016/j.euf.2019.03.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2018] [Revised: 02/12/2019] [Accepted: 03/04/2019] [Indexed: 11/29/2022]
|
9
|
Karabay E, Karsiyakali N, Cinier G, Zeren G, Duvar S, Simsek B, Aslan AR, Karabay CY. Change in Frequency and Predictors of Erectile Dysfunction With Changes in the International Index of Erectile Function-Erectile Function Domain Score in Patients With ST-Elevation Myocardial Infarction: A Prospective, Longitudinal Study. J Sex Med 2020; 17:1101-1108. [PMID: 32222434 DOI: 10.1016/j.jsxm.2020.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2020] [Revised: 02/11/2020] [Accepted: 03/02/2020] [Indexed: 11/25/2022]
Abstract
BACKGROUND Erectile dysfunction (ED) has been proposed as an early indicator for future coronary and peripheral vascular disease. AIM We aimed to investigate the longitudinal change in proportion and predictors for ED with changes in erectile function domain (EFD) of the International Index of Erectile Function-15 (IIEF-15) in patients with ST-segment elevation myocardial infarction (STEMI) who underwent primary percutaneous coronary intervention (PPCI). METHODS Between December 2018 and June 2019, 286 male patients aged between 40 and 70 years who were treated with PPCI for STEMI were included. The patients were asked to complete the IIEF-EFD form 3 days after the procedure for the evaluation of baseline erectile functions. During follow-up 3 months after the index procedure, the patients were asked to refill the IIEF-EFD form. Both baseline and third-month IIEF-EFD scores were calculated, and the patients were classified into ED severity groups as per the IIEF-EFD scores. A linear mixed model was used to identify predictors of ED at 3 months. OUTCOMES This study identifies the prevalence and predictors of ED with STEMI who underwent PPCI. RESULTS The median age was 54 (range 48-61) years. The median IIEF-EFD scores at 3 days and 3 months were 25.5 (range 20.0-27.0) and 22.00 (range 18.25-25.00), respectively. Half of the patients were found to have ED with varying severity as per baseline IIEF-EFD scores. This rate increased to 79% at the 3-month follow-up visit. The IIEF-EFD scores of the patients decreased over time (P < .001). Advanced age (β = -0.603, se = 0.192, P = .002), presence of three-vessel coronary artery disease (β = -3.828, se = 0.783, P < .001), and diabetes (β = -2.934, se = 0.685, P < .001) were found to be inversely associated with the IIEF-EFD scores. CLINICAL IMPLICATIONS Advanced age, presence of three-vessel disease, and diabetes mellitus are the indicators of sexual rehabilitation needs in patients after STEMI. STRENGTHS & LIMITATIONS This is the first study investigating the predictor variables for the development of ED after coronary artery disease treatment. The limitations include the lack of evaluation of anxiety and depression and the measurements of testosterone levels. CONCLUSION The prevalence of ED was high among patients with coronary artery disease, and the frequency of ED increased during 3-month follow-up. Advanced age, three-vessel disease, and diabetes were significant predictors of ED with changes in IIEF-EFD score in patients with STEMI who underwent PPCI. Karabay E, Karsiyakali N, Cinier G, et al. Change in Frequency and Predictors of Erectile Dysfunction With Changes in the International Index of Erectile Function-Erectile Function Domain Score in Patients With ST-Elevation Myocardial Infarction: A Prospective, Longitudinal Study. J Sex Med 2020;17:1101-1108.
Collapse
Affiliation(s)
- Emre Karabay
- Department of Urology, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | | | - Goksel Cinier
- Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Gonul Zeren
- Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Serdar Duvar
- Department of Urology, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Barıs Simsek
- Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Ahmet Ruknettin Aslan
- Department of Urology, Haydarpasa Numune Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| | - Can Yucel Karabay
- Department of Cardiology, Dr Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, University of Health Sciences, Istanbul, Turkey
| |
Collapse
|
10
|
Ruiz-García A, Arranz-Martínez E, Cabrera-Vélez R, Palacios-Martínez D, Rivera-Teijido M, García-Álvarez JC, Morales-Cobos LE, Moreno-Fernández JC, García-Fernández ME, Peña-Antón N, Díez-Pérez MC, Montero-Costa A, Lorenzo-Borda MS, García-Granado MD, Casaseca-Calvo TF, Cique-Herráinz JA, García-Villasur MP, Marañón-Henrich N, Zarzuelo-Martín N, Baltuille-Aller MC, Arribas-Álvaro P, Macho-Barrio AI, Ribot-Catalá C, Capitán-Caldas M, Ciria-de-Pablo C, Sanz-Velasco C, Vargas-Machuca-Cabañero C, Simonaggio-Stancampiano P, Cabello-Igual MP, Sarria-Sánchez MT. Prevalence of erectile dysfunction in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-ED study. CLINICA E INVESTIGACION EN ARTERIOSCLEROSIS 2019; 31:101-110. [PMID: 30979438 DOI: 10.1016/j.arteri.2019.01.002] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/20/2018] [Revised: 10/09/2018] [Accepted: 01/02/2019] [Indexed: 02/07/2023]
Abstract
INTRODUCTION Few studies conducted in primary care setting report about age-adjusted prevalence rates of erectile dysfunction (ED). Aims of SIMETAP-ED study were to determine crude and age-adjusted prevalence rates of ED diagnosis, to compare these rates with other similar studies, and to compare prevalence rates of cardiovascular risk factors (CVRF), cardiovascular diseases (CVD), metabolic diseases and chronic kidney disease (CKD) between populations with and without ED. METHODS Cross-sectional observational study conducted in primary care setting. Population-based random sample: 2934 adult men. Response rate: 66%. A clinical interview was conducted to diagnose ED using a question derived from ED definition. The medical records of patients were reviewed to identify their CVRF and diseases associated with ED. The age-adjustments were standardized to Spanish population. RESULTS The prevalence rates of metabolic diseases, CVD, CVRF, and CKD in population with ED were higher than population without ED, highlighting the CVD. The crude prevalence of ED was 17.2% (95% confidence interval: 15.8-18.6). The age-adjusted prevalence rates of ED were 0.71% in men under 40 years, 12.4% in men over 18 years, 10.8% in men aged 40-69 years, 18.9% in men over 40 years, and 48.6% in men over 70 years. CONCLUSIONS SIMETAP-ED study showed association of ED with metabolic diseases, CKD, CVRF, and highlighting CVD. The age-adjusted prevalence of ED was 12.4% in adult men, 19% in men over 40 years, and almost 50% in men over 70 years.
Collapse
Affiliation(s)
- Antonio Ruiz-García
- University Health Center Pinto, Lipids and Cardiovascular Prevention Unit, Madrid Health Service, C/ Marqués, s/n, 28320 Pinto-Madrid, Spain.
| | | | - Roberto Cabrera-Vélez
- University Health Center Espronceda, Madrid Health Service, C/ Espronceda 24, 28003 Madrid, Spain
| | - David Palacios-Martínez
- University Health Center Isabel II, Madrid Health Service, C/ Isabel II, 15, 28982 Parla-Madrid, Spain
| | - Montserrat Rivera-Teijido
- University Health Center Isabel II, Madrid Health Service, C/ Isabel II, 15, 28982 Parla-Madrid, Spain
| | - Juan Carlos García-Álvarez
- University Health Center Dr. Mendiguchia Carriche, Madrid Health Service, Pza. Comunidad de Madrid s/n, 28914 Leganés-Madrid, Spain
| | - Luis Enrique Morales-Cobos
- University Health Center Las Americas, Madrid Health Service, Av. de América, 6, 28981 Parla-Madrid, Spain
| | | | | | - Nuria Peña-Antón
- Health Center El Restón, Madrid Health Service, Av. del Mar Mediterráneo, 1, 28341 Valdemoro-Madrid, Spain
| | - Maria Cruz Díez-Pérez
- Health Center Los Cármenes, Madrid Health Service, C/ Vía Carpetana, 202, 28047 Madrid, Spain
| | | | | | | | | | - Juan A Cique-Herráinz
- Health Center Torito, Madrid Health Service, Camino de vinateros 140, 28030 Madrid, Spain
| | | | - Nuria Marañón-Henrich
- Health Center Las Olivas, Madrid Health Service, P° Deleite, 30, 28300 Aranjuez-Madrid, Spain
| | - Nieves Zarzuelo-Martín
- Health Center Las Olivas, Madrid Health Service, P° Deleite, 30, 28300 Aranjuez-Madrid, Spain
| | | | - Pilar Arribas-Álvaro
- Health Center Campamento, Madrid Health Service, C/ Mirueña s/n, 28024 Madrid, Spain
| | - Ana Isabel Macho-Barrio
- Health Center Vicente Soldevilla, Madrid Health Service, C/ Sierra de Alquife 8, 28053 Madrid, Spain
| | - Carlos Ribot-Catalá
- Health Center Jaime Vera, Madrid Health Service, Av. Europa 1, 28915 Leganés-Madrid, Spain
| | - Mercedes Capitán-Caldas
- Health Center Las Ciudades, Madrid Health Service, C/ Palestina s/n, 28903 Getafe-Madrid, Spain
| | - Cristina Ciria-de-Pablo
- Health Center Hoyo de Manzanares, Madrid Health Service, Pza. Cervantes s/n, 28260 Hoyo de Manzanares-Madrid, Spain
| | - Carmelina Sanz-Velasco
- University Health Center Sector III, Madrid Health Service, Av. Juan Carlos I, 1, 28905 Getafe-Madrid, Spain
| | | | - Paula Simonaggio-Stancampiano
- Health Center San Martin de la Vega, Madrid Health Service, Av. Doce de Octubre, 6, 28330 San Martín de la Vega-Madrid, Spain
| | - María Pilar Cabello-Igual
- Health Center Parque Europa, Madrid Health Service, Pza. David Martín s/n, 28320 Pinto-Madrid, Spain
| | | | | | | |
Collapse
|
11
|
|
12
|
|
13
|
Colson M, Cuzin B, Faix A, Grellet L, Huyghes E. Current epidemiology of erectile dysfunction, an update. SEXOLOGIES 2018. [DOI: 10.1016/j.sexol.2018.01.018] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
|
14
|
Colson M, Cuzin B, Faix A, Grellet L, Huyghes E. Cœur et sexe, quoi de neuf ? SEXOLOGIES 2018. [DOI: 10.1016/j.sexol.2018.01.010] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
15
|
Pallangyo P, Nicholaus P, Kisenge P, Mayala H, Swai N, Janabi M. A community-based study on prevalence and correlates of erectile dysfunction among Kinondoni District Residents, Dar Es Salaam, Tanzania. Reprod Health 2016; 13:140. [PMID: 27899129 PMCID: PMC5129661 DOI: 10.1186/s12978-016-0249-2] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2016] [Accepted: 10/20/2016] [Indexed: 01/28/2023] Open
Abstract
BACKGROUND Globally, erectile dysfunction burden (ED) is rising appreciably and it is projected to affect about 332 million men by the year 2025. This rise is attributable to the rising incidence of conditions associated with ED including obesity, diabetes, hypertension, coronary artery disease and depression. We conducted this community-based screening to elucidate on the prevalence of ED and its associated factors among men residing in an urban community in Tanzania. METHODS We conducted a cross-sectional community-based study and interviewed 441 men aged at least 18 years. Diabetes and hypertension were defined as per the International Diabetes Federation (IDF) and the 7th Report of the Joint National Committee (JNC 7) respectively. The 5-item version of the International Index of Erectile Function (IIEF-5) Scale was used to assess for erectile dysfunction. Multivariate logistic regression analyses were performed to explore the factors associated with ED. RESULTS The mean age was 47.1 years, 57.6 % had excess body weight, 8.2 % had diabetes and 61.5 % had high blood pressure. Overall, 24 % (106/441) of men in this study had some form of ED. Participants with age ≥55, positive smoking history, obesity, diabetes and hypertension displayed highest rates of ED in their respective subgroups. However, age ≥40 and diabetes were ultimately the strongest factors for ED after multivariate logistic regression analyses, (OR 5.0, 95 % CI 2.2-11.2, p < 0.001 and OR 5.3, 95 % CI 2.2-12.7, p < 0.001 respectively). CONCLUSION Erectile dysfunction affects about a quarter of adult men living in Kinondoni district. Old age, obesity, smoking, hypertension and diabetes have the potential to increase the odds of ED up-to 5 times. In view of this, men with diabetes and hypertension should be offered screening services and treatment of ED as an integral component in their management.
Collapse
Affiliation(s)
- Pedro Pallangyo
- Department of Adult Cardiovascular Medicine, Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania. .,Unit of Research, Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania.
| | - Paulina Nicholaus
- Department of Adult Cardiovascular Medicine, Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania
| | - Peter Kisenge
- Department of Adult Cardiovascular Medicine, Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania
| | - Henry Mayala
- Department of Adult Cardiovascular Medicine, Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania
| | - Noel Swai
- Department of Adult Cardiovascular Medicine, Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania
| | - Mohamed Janabi
- Department of Adult Cardiovascular Medicine, Jakaya Kikwete Cardiac Institute, P.O. Box 65141, Dar es Salaam, Tanzania
| |
Collapse
|
16
|
Lubna NJ, Nakamura Y, Cao X, Wada T, Izumi-Nakaseko H, Ando K, Sugiyama A. Cardiac safety profile of sildenafil: chronotropic, inotropic and coronary vasodilator effects in the canine isolated, blood-perfused heart preparations. J Toxicol Sci 2016; 41:739-744. [PMID: 27853102 DOI: 10.2131/jts.41.739] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/02/2022]
Abstract
Sildenafil is a phosphodiesterase type-5 inhibitor. We evaluated the effects of sildenafil on the sinoatrial rate, developed tension of the papillary muscle and coronary blood flow by using the canine isolated, blood-perfused sinoatrial node and papillary muscle preparations. The former preparation had a regular automaticity rate of 106 ± 1 beats/min (n = 4), whereas the latter showed a developed tension of 22 ± 4 mN (n = 4) and a coronary blood flow of 3.9 ± 0.1 mL/min (n = 4). Intracoronary injection of 10, 30 and 100 µg of sildenafil, which would provide about 20 to 200 times higher plasma drug concentrations than its therapeutic level, increased the automaticity rate by 4, 12 and 22%, the developed tension by 19, 55 and 118% and the coronary blood flow by 42, 95 and 142%, respectively. These results indicate that supratherapeutic concentration of sildenafil possesses direct positive chronotropic and inotropic effects together with a coronary vasodilator action, confirming that caution has to be paid on the use of sildenafil for patients with ischemic heart diseases, obstructive hypertrophic cardiomyopathy and/or ventricular arrhythmias. The information on sildenafil reported in this study may help establish a guidance on cardiac safety assessment of newer phosphodiesterase type-5 inhibitors.
Collapse
|
17
|
Ruzek L, Konecny T, Soucek F, Konecny D, Mach L, Ommen SR, Kopecky SL, Nishimura RA. Phosphodiesterase 5 Inhibitor Use in Men With Hypertrophic Cardiomyopathy. Am J Cardiol 2015; 116:618-21. [PMID: 26141201 DOI: 10.1016/j.amjcard.2015.05.022] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/20/2015] [Revised: 05/07/2015] [Accepted: 05/07/2015] [Indexed: 11/28/2022]
Abstract
The prevalence of sexual dysfunction (SD) in men with hypertrophic cardiomyopathy (HC) remains unknown, yet its clinical relevance may be high given that its treatment-phosphodiesterase 5 inhibitors (PDE5i)-can increase the left ventricular outflow tract pressure gradient. In this retrospective study, we evaluated the medical records of consecutively seen men with HC for the evidence of SD (defined as SD diagnosis noted in the medical record, the use of medications unique for SD, or SD reported by the patient on a routine clinical questionnaire). Of the 283 consecutively seen men with HC (mean age 52.9 ± 14.1 years), 63 patients (22%) with SD were identified. Of those with SD, 38% were recorded as regularly using PDE5i. In conclusion, SD and the use of PDE5i present a relatively common occurrence in men with HC, and further studies are needed to develop an evidence-guided algorithm for safe implementation of SD therapies in this most common inherited cardiomyopathy.
Collapse
Affiliation(s)
- Lukas Ruzek
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic; Department of Anesthesiology and Intensive Care, St. Anne's University Hospital Brno, Brno, Czech Republic
| | - Tomas Konecny
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
| | - Filip Soucek
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
| | - Dana Konecny
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
| | - Lukas Mach
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota; Department of Cardiovascular Diseases, International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic
| | - Steve R Ommen
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota
| | - Stephen L Kopecky
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota
| | - Rick A Nishimura
- Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minnesota
| |
Collapse
|
18
|
Cordero A, Bertomeu-Martínez V, Mazón P, Fácila L, González-Juanatey JR. Erectile Dysfunction May Improve by Blood Pressure Control in Patients with High-Risk Hypertension. Postgrad Med 2015; 122:51-6. [DOI: 10.3810/pgm.2010.11.2223] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
19
|
Zhu X, Lin H, Jiang R, Wang R, Jiang J, Peng Q, Fan Z. Improving erectile function of spontaneously hypertensive rats by silencing ROCK2. Urology 2015; 84:983.e11-8. [PMID: 25260465 DOI: 10.1016/j.urology.2014.06.043] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/02/2014] [Revised: 06/20/2014] [Accepted: 06/27/2014] [Indexed: 12/25/2022]
Abstract
OBJECTIVE To improve the erectile function of spontaneously hypertensive rats (SHRs) by silencing Rho-associated protein kinase 2 (ROCK2). METHODS Wistar-Kyoto rats (WKYs) and SHRs injected with 20-μL saline (WKY saline control and SHR saline control; n = 10) or 20 μL of 3 × 10(6) transducing units per milliliter negative control lentivirus (WKY negative control and SHR negative control; n = 10) were set as controls. After selecting the best inhibitory small interference ribonucleic acid (siRNA) by transducing 4 kinds of the lentiviral vector-based siRNA-targeting ROCK2 messenger ribonucleic acid (mRNA) respectively into cultured cavernous smooth muscle cells, 20 μL of 3 × 10(6) transducing units per milliliter of the lentiviral vectors were prepared and injected into the corpora cavernosa of WKYs (WKY siRNA; n = 10) and SHRs (SHR siRNA; n = 10). Seven days later, the maximum intracavernosal pressure to mean arterial pressure ratio (ICPmax/MAP), the expression levels of ROCK2, endothelial nitric oxide synthase (eNOS), and phosphorylated eNOS in the penis were measured and determined. RESULTS In cavernous smooth muscle cells of SHR culture, 3 kinds of ROCK2 siRNA significantly inhibited ROCK2 mRNA expression. The lentiviral vector-based siRNA-targeting ROCK2 mRNA at the 2287th nucleotide position significantly increased the ICPmax/MAP in the SHR siRNA group more than in SHR saline control and SHR negative control groups. There was no significant difference in the ICPmax/MAP among WKY saline control, WKY negative control and WKY siRNA groups. The ICPmax/MAP in the SHR siRNA group was significantly lower than that in the WKY saline control group. ROCK2 expression in the penis was significantly decreased in SHR siRNA group compared with that in SHR saline control and SHR negative control groups. The expression of eNOS and phosphorylated eNOS was significantly increased in SHR siRNA compared with that in SHR saline control and SHR negative control groups. CONCLUSION The gene therapy with lentiviral vector-based siRNA-targeting ROCK2 mRNA can significantly improve erectile function mainly by directly inhibiting ROCK2 pathway in the SHR.
Collapse
Affiliation(s)
- Xiubo Zhu
- Department of Cardiovascular Diseases, Affiliated Hospital, Luzhou Medical College, Luzhou, China
| | - Haocheng Lin
- Department of Surgery, The University of Texas Medical School at Houston, Houston, TX
| | - Rui Jiang
- Department of Urology, Affiliated Hospital, Luzhou Medical College, Luzhou, China.
| | - Run Wang
- Department of Surgery, The University of Texas Medical School at Houston, Houston, TX
| | - Jun Jiang
- Department of Vascular Surgery, Affiliated Hospital, Luzhou Medical College, Luzhou, China
| | - Qiang Peng
- Department of Urology, Affiliated Hospital, Luzhou Medical College, Luzhou, China
| | - Zhongcai Fan
- Department of Cardiovascular Diseases, Affiliated Hospital, Luzhou Medical College, Luzhou, China
| |
Collapse
|
20
|
Al Naimi A, Majzoub AA, Talib RA, Canguven O, Al Ansari A. Erectile dysfunction in qatar: prevalence and risk factors in 1,052 participants-a pilot study. Sex Med 2014; 2:91-5. [PMID: 25356303 PMCID: PMC4184678 DOI: 10.1002/sm2.26] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022] Open
Abstract
AIM The aim of this study is to investigate the prevalence of erectile dysfunction (ED) in Qatar and to determine the risk factors associated with it. MATERIALS AND METHODS This is a cross-sectional survey study of men attending the outpatient department at Hamad Medical Corporation in Qatar between February 2012 and February 2013. The International Index of Erectile Function (IIEF)-5 questionnaire was used for data collection. In addition to the IIEF-5 score, each participant's medical history was taken, with special emphasis on risk factors for ED, including diabetes mellitus (DM), hypertension (HTN), dyslipidemia, coronary artery disease (CAD), and smoking habits, and on their body mass index. RESULTS One thousand fifty-two participants were randomly selected to fill out the IIEF-5 questionnaire. The participants' mean age (±SD) was 41.87 ± 13.24 years. Analysis of replies to the IIEF-5 showed that ED was present in 573 out of 1,052 participants (54.5%). Fifty-six (5%) participants had severe ED, 61 (6%) had moderate ED, 173 (16%) had mild to moderate ED, and 283 (27%) had mild ED. Risk factors for ED that held statistical significance were age (odds ratio [OR] = 2.9, 95% confidence interval [CI] 2.1-4.1, P < 0.001), DM (OR = 2.6, 95% CI 1.7-3.9, P < 0.001), HTN (OR = 1.6, 95% CI 1.1-2.5, P = 0.012), dyslipidemia (OR = 1.5, 95% CI 1.1-2.4, P = 0.024), and CAD (OR = 3.2, 95% CI 1.3-7.5, P = 0.009). CONCLUSION We found that the prevalence rate of ED in Qatar is quite similar to the regional reported rates. Overall, we demonstrated that nearly more than half of our participants suffered from ED. Besides age, DM, HTN, CAD, and dyslipidemia were found to be the most important risk factors for ED. Al Naimi A, Majzoub AA, Talib RA, Canguven O, and Al Ansari A. Erectile dysfunction in Qatar: Prevalence and risk factors in 1,052 participants-A pilot study. Sex Med 2014;2:91-95.
Collapse
Affiliation(s)
| | - Ahmad A Majzoub
- Department of Urology, Hamad Medical Corporation Doha, Qatar
| | - Raidh A Talib
- Department of Urology, Hamad Medical Corporation Doha, Qatar
| | - Onder Canguven
- Department of Urology, Hamad Medical Corporation Doha, Qatar
| | | |
Collapse
|
21
|
Li Y, Jiang J, He Y, Jiang R, Liu J, Fan Z, Cheng Y. Icariin Combined with Breviscapine Improves the Erectile Function of Spontaneously Hypertensive Rats. J Sex Med 2014; 11:2143-52. [DOI: 10.1111/jsm.12614] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
22
|
Ettala OO, Syvänen KT, Korhonen PE, Kaipia AJ, Vahlberg TJ, Boström PJ, Aarnio PT. High‐Intensity Physical Activity, Stable Relationship, and High Education Level Associate with Decreasing Risk of Erectile Dysfunction in 1,000 Apparently Healthy Cardiovascular Risk Subjects. J Sex Med 2014; 11:2277-84. [DOI: 10.1111/jsm.12618] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
|
23
|
Ariba AJ, Oladapo OT, Iyaniwura CA, Dada OA. Management of erectile dysfunction: perceptions and practices of Nigerian primary care clinicians. S Afr Fam Pract (2004) 2014. [DOI: 10.1080/20786204.2007.10873632] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
|
24
|
Expression of Sphingosine 1-Phosphate 1-3 on Penile Cavernous Tissue in Hypertensive and Normotensive Rats. Urology 2014; 84:490.e7-13. [DOI: 10.1016/j.urology.2014.04.039] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2014] [Revised: 04/08/2014] [Accepted: 04/26/2014] [Indexed: 11/23/2022]
|
25
|
The connection between type 2 diabetes and erectile dysfunction in Taiwanese aboriginal males. Int J Impot Res 2014; 26:235-40. [DOI: 10.1038/ijir.2014.26] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/25/2013] [Revised: 06/03/2014] [Accepted: 06/13/2014] [Indexed: 12/15/2022]
|
26
|
Frederick LR, Cakir OO, Arora H, Helfand BT, McVary KT. Undertreatment of erectile dysfunction: claims analysis of 6.2 million patients. J Sex Med 2014; 11:2546-53. [PMID: 25059314 DOI: 10.1111/jsm.12647] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
INTRODUCTION Prior research conducted on treatment of erectile dysfunction (ED) has been derived from surveys involving relatively small populations of men. There are needs for large population-based studies in this area. Our study addresses that need. AIM The aim of this study was to characterize ED treatment among a large population of men. METHODS Patients ≥30 years in commercial insurance dataset with diagnosis code for ED during 12-month period ending June 2011 were identified. Men were considered "treated" if prescription was filled for phosphodiesterase type 5 inhibitor (PDE5i), injection or urethral prostaglandins, or androgen replacement (ART) during study period. "Untreated" patients received the diagnosis but did not fill prescription. Statistical analyses were used to compare prescription frequency with clinical characteristics, including age and comorbidities. MAIN OUTCOME MEASURES ED treatment rates among large population of insured men, treatment types employed, patient demographics, associated medical comorbidities of this population, and prescriber details were the main outcome measures. RESULTS Only 25.4% of 6,228,509 men with ED were treated during study period. While PDE5is were the most commonly prescribed medical therapy (75.2%), ART was utilized as monotherapy or in combination therapy in 30.6% of men. ART was significantly (P < 0.0001) more frequently used in men <40 and >65 years. Although ED frequency was associated with increased age and number of comorbidities, men >60 years were significantly (P < 0.0001) less likely to be treated compared with men aged 40-59 years. Additionally, treatment frequency did not vary as a function of number of comorbidities. However, compared with men with prostate cancer, men with comorbid hypogonadism, sleep disorders, benign prostatic hyperplasia, or components of metabolic syndrome were (P < 0.0001) more likely to be treated. CONCLUSIONS Despite high prevalence of ED with age and comorbidities, most men continue receiving no treatment. Although benefits of medical intervention for ED are well-recognized, many barriers to treatment continually exist including physician, patient and partner preference and knowledge.
Collapse
Affiliation(s)
- Luke R Frederick
- Division of Urology, Southern Illinois University School of Medicine, Springfield, IL, USA
| | | | | | | | | |
Collapse
|
27
|
Holden CA, Collins VR, Handelsman DJ, Jolley D, Pitts M. Healthy aging in a cross-sectional study of Australian men: what has sex got to do with it? Aging Male 2014; 17:25-9. [PMID: 24491170 DOI: 10.3109/13685538.2013.843167] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
AIM To identify lifestyle factors associated with healthy aging in middle-aged and older Australian men. METHODS A cross-sectional, population-based, computer-assisted telephone interview study explored self-reported health outcomes, and associated determinants for general and reproductive health (the Men in Australia Telephone Survey) in men aged 40 years and older (n = 5990). "Good health" was defined by self-reported health (excellent/very good) combined with absence of self-reported high blood pressure, heart disease, stroke, diabetes and depression symptoms. Categories of sexual activity frequency in the previous four weeks ranged from zero to 12+ times. RESULTS "Good health" declined with increasing age with 17% of men over 70 years reporting "good health". In multivariable logistic regression models, significant inverse associations were found between modifiable lifestyle factors - both underweight and overweight/obesity, physical inactivity, smoking and high alcohol consumption - and "good health". Low-risk alcohol intake and living with a partner were positively associated with "good health". Sexual activity was also positively associated with "good health" (p < 0.001) with elevated odds ratios (ORs) for each category of frequency of sexual activity (1-4, 5-8, 9-12 or 12+ times in the past 4 weeks) relative to zero frequency (ORs 1.68 to 2.16). CONCLUSION This study suggests that sexual activity is an important correlate of retaining good health in middle- and older-aged men, independent of other behavioral determinants.
Collapse
Affiliation(s)
- Carol A Holden
- Andrology Australia, School of Public Health and Preventive Medicine, Monash University , Victoria , Australia
| | | | | | | | | |
Collapse
|
28
|
Data on the utilization of treatment modalities for ED in Taiwan in the era of PDE5 inhibitors. Int J Impot Res 2014; 26:141-5. [DOI: 10.1038/ijir.2013.53] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2013] [Revised: 09/09/2013] [Accepted: 12/20/2013] [Indexed: 11/08/2022]
|
29
|
|
30
|
Omidvar S, Niaki MT, Amiri FN, Kheyrkhah F. Sexual dysfunction among women with diabetes mellitus in a diabetic center in Amol. J Nat Sci Biol Med 2013; 4:321-4. [PMID: 24082725 PMCID: PMC3783773 DOI: 10.4103/0976-9668.116992] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
Background: Sexual disorders among diabetic men have been proved in different studies but sexual dysfunction of diabetic women has received attention only recently. Neuropathy, vascular impairment, and psychological complaints have been implicated in the pathogenesis of decreased libido, low arousability, decreased vaginal lubrication, orgasmic dysfunction, and dyspareunia among diabetic women. Aim: The aim of this research was to study the prevalence of sexual dysfunction in different areas among diabetic women. Materials and Methods: A cross-sectional study was conducted on 500 women who were recruited from a diabetes center, based on questionnaires completed by them. Data regarding demographic features, physical complications, and sexual disorders were obtained. Medical records of patients were used to obtain body mass index (BMI) and details of complications. Results: Mean age of participants, duration of diabetes, and BMI was 48.8 ± 0.4, 8.9 ± 0.32 years, and 28.9 ± 0.23, respectively. Prevalence of sexual dysfunction was 32.3%. Low sexual desire was seen in 81.8%, disorders of arousal in 78.3%, of orgasm in 47.5%, and 35.1% had disorder in resolution area. There was no significant relationship between some factors such as age, duration of diabetes, BMI, and frequency of sexual dysfunction. Frequency of diabetic complications demonstrated a significant effect on the prevalence of sexual dysfunction. Conclusion: Sexual problems are frequent among diabetic women and deserve more attention in clinical practice and researches.
Collapse
Affiliation(s)
- Shabnam Omidvar
- Department of Nursing and Midwifery, Babol Medical Sciences University, Iran
| | | | | | | |
Collapse
|
31
|
Brock G, Harper W. Dysfonction érectile. Can J Diabetes 2013. [DOI: 10.1016/j.jcjd.2013.07.038] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
32
|
Simsek A, Ozbek E, Oncu M. Effect of tadalafil and 3-hydroxy-3-methylglutaryl coenzyme A inhibitor statin on the haemodynamics of cavernous and brachial arteries. Andrologia 2013; 46:808-13. [DOI: 10.1111/and.12153] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/25/2013] [Indexed: 11/26/2022] Open
Affiliation(s)
- A. Simsek
- Department of Urology; Haseki Training and Research Hospital; Istanbul Turkey
| | - E. Ozbek
- Department of Urology; Okmeydani Training and Research Hospital; Istanbul Turkey
| | - M. Oncu
- Department of Radiodiagnostics; Okmeydani Training and Research Hospital; Istanbul Turkey
| |
Collapse
|
33
|
Ishizuka O, Matsuyama H, Sakai H, Matsubara A, Nagaoka A, Takahashi S, Takeda M, Ozono S, Shiroki R, Shuin T, Hara I, Kakizaki H, Tsukamoto T, Yamanishi T, Yokoyama O, Kakehi Y, Nishizawa O. Nocturia Potentially Influences Maintenance of Sexual Function in Elderly Men with Benign Prostatic Hyperplasia. Low Urin Tract Symptoms 2013; 5:75-81. [PMID: 26663374 DOI: 10.1111/j.1757-5672.2012.00173.x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
OBJECTIVE This study examined the relationship between bothersome symptoms of nocturia and erectile function. METHODS Subjects comprised patients with lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Patients were prospectively followed on treatment with the alpha-1 blocker naftopidil for 8 weeks. Patient backgrounds and efficacy of naftopidil associated with LUTS and sexual activity were evaluated. RESULTS The percentage of patients who identified nocturia as the most bothersome symptom was 30.2% (n = 135), representing the highest percentage among International Prostate Symptom Score (IPSS) items. The number of patients with nocturia as the most bothersome symptom plateaued at an IPSS for nocturia of two or three points. In contrast, the number of patients with slow stream as the most bothersome symptom increased with symptom severity according to IPSS for slow stream. Logistic regression analysis on association between nocturia and erectile function confirmed that the odds ratio was 1.41 (P < 0.05). Naftopidil showed excellent efficacy related to male LUTS, but International Index of Erectile Function 5 (IIEF5) total score was almost unchanged. Among patients with nocturia improved by naftopidil, IIEF5 total score was significantly changed in the group with IPSS nocturia score ≤1 as compared to the group with IPSS nocturia score ≥2 per night (P = 0.038). CONCLUSION Nocturia the most bothersome symptom correlated with aging. Nocturia could associate erectile dysfunction, and keeping the frequency of nocturia at ≤1 episode might be meaningful for maintaining quality of life in elderly men.
Collapse
Affiliation(s)
- Osamu Ishizuka
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Hideyasu Matsuyama
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Hideki Sakai
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Akio Matsubara
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Akira Nagaoka
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Satoru Takahashi
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Masayuki Takeda
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Seiichiro Ozono
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Ryoichi Shiroki
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Taro Shuin
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Isao Hara
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Hidehiro Kakizaki
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Taiji Tsukamoto
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Tomonori Yamanishi
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Osamu Yokoyama
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Yoshiyuki Kakehi
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | - Osamu Nishizawa
- Department of Urology, Shinshu University School of Medicine, MatsumotoDepartment of Urology, Graduate School of Medicine, Yamaguchi University, UbeDepartment of Nephro-Urology, Nagasaki University Graduate School of Biomedical Sciences, NagasakiDepartment of Urology, Hiroshima University Graduate School of Biomedical Sciences, HiroshimaDepartment of Urology, Faculty of Medicine, Yamagata University, YamagataDepartment of Urology, Nihon University School of Medicine, TokyoDepartment of Urology, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, YamanashiDepartment of Urology, Hamamatsu University School of Medicine, HamamatsuDepartment of Urology, Fujita Health University School of Medicine, ToyoakeDepartment of Urology, Kochi Medical School, KochiDepartment of Urology, Wakayama Medical University, WakayamaDepartment of Renal and Urologic Surgery, Asahikawa Medical University, AsahikawaDepartment of Urology, Sapporo Medical University School of Medicine, SapporoDepartment of Urology, Dokkyo Medical University, Tochigi, JapanDepartment of Urology, Faculty of Medical Science, University of Fukui, EiheijiDepartment of Urology, Kagawa University Faculty of Medicine, Kita-gun, Japan
| | | |
Collapse
|
34
|
Kang SG, Kim JJ. Udenafil: efficacy and tolerability in the management of erectile dysfunction. Ther Adv Urol 2013; 5:101-10. [PMID: 23554845 DOI: 10.1177/1756287212470019] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Udenafil is a potent novel phosphodiesterase-5 inhibitor approved for use in Korea. Udenafil has unique properties, with a T max of 1.0-1.5 h and a T 1/2 of 11-13 h (a relatively rapid onset and a long duration of action). Therefore, both on-demand and once-daily use of udenafil have been reported. Udenafil's efficacy and tolerability have been evaluated in several studies, and recent and continuing studies have demonstrated udenafil's promise in both dosing regimens. Presently, tadalafil is the only FDA-approved drug for daily dosing, but udenafil can be used as a once-daily dose for erectile dysfunction patients who cannot tolerate tadalafil due to phosphodiesterase subtype selectivity. Udenafil as an on-demand or once-daily dose is effective and tolerable, but more studies are needed in patients of other ethnicities and with comorbid conditions such as diabetes mellitus, hypertension, and benign prostate hyperplasia.
Collapse
Affiliation(s)
- Sung Gu Kang
- Department of Urology, Korea University School of Medicine
| | | |
Collapse
|
35
|
|
36
|
Affiliation(s)
- André T Guay
- Center for Sexual Function, Lahey Clinic, Burlington, Massachusetts, USA.
| |
Collapse
|
37
|
Cakmak HA, Ikitimur B, Karadag B, Ongen Z. An unusual adverse effect of sildenafil citrate: acute myocardial infarction in a nitrate-free patient. BMJ Case Rep 2012; 2012:bcr-2012-006504. [PMID: 23087267 DOI: 10.1136/bcr-2012-006504] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
Myocardial infarction (MI) associated with sildenafil citrate is seen rarely in patients without any history of coronary artery disease. We report a nitrate-free patient with a history of cardiovascular risk factors who developed acute MI after taking sildenafil. A 44-year-old man diagnosed with acute anterior ST segment elevation MI 120 min after self-administration of 150 mg sildenafil was admitted before attempting any sexual intercourse. The coronary angiography revealed 99% occlusion of the left anterior descending artery (LAD) and a bare-metal stent was implanted. He was discharged after 5 days without any complication. Sildenafil may cause coronary steal or may lead to vasodilation causing hypotension in patient with pre-existing cardiovascular disease, especially in patients on nitrate therapy. Our patient was nitrate free, with normal blood pressure values. Emotional stimulation associated with anticipated sexual activity may have been a triggering factor for vulnerable coronary plaque rupture.
Collapse
Affiliation(s)
- Huseyin Altug Cakmak
- Department of Cardiology, Istanbul University Cerrahpasa Medical Faculty, Istanbul, Turkey.
| | | | | | | |
Collapse
|
38
|
Influence of socio-demographic characteristics on prevalence of erectile dysfunction in Nigeria. Int J Impot Res 2012; 25:18-23. [PMID: 22895099 DOI: 10.1038/ijir.2012.28] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
Data on erectile dysfunction (ED) in Nigeria are limited. The study determined the influence of socio-demographic characteristics on ED prevalence in Ilorin, Nigeria. A sample of 399 married men aged 20-70 years was taken. They responded to a questionnaire adapted to reflect the local cultures. Data on socio-demographic characteristics, current use of penile erectile enhancers and erectile function were obtained. Erectile function was assessed using the abridged five-item version of the International Index of Erectile Function (IIEF-5). Presence of ED was defined as IIEF-5 score of <21. Descriptive and test statistics were applied to the quantitative data. The results revealed ED prevalence of 46.9% with 34.3, 9.8 and 2.8% having mild, moderate and severe ED, respectively. Men aged 40-64 years, reported severe ED from 9.1 to 36.4%. Yoruba ethnic group had the highest ED prevalence. Of the variables, age, length of marriage and spousal status were significantly associated and correlated with ED (P<0.05), while ethnicity, religion and age at first marriage were not (P>0.05). With an aging population, ED may become a significant health problem in similar environments in Nigeria.
Collapse
|
39
|
Hirooka N, Lapp DP. Erectile dysfunction as an initial presentation of diabetes discovered by taking sexual history. BMJ Case Rep 2012; 2012:bcr.12.2011.5289. [PMID: 22605862 DOI: 10.1136/bcr.12.2011.5289] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
Abstract
This case, as an important clinical reminder, will illustrate improvement of a patient's quality of life and care in chronic diseases through sexual history taking in the primary care setting. The case report also includes recommended investigation for erectile dysfunction (ED). Family physicians need to maintain awareness of sexual dysfunction as part of the history taking during a general medical investigation to avoid leaving sexual issues untreated including ED. If left untreated, ED can lead to psychological trauma, frustration and lower self-esteem. Additionally, ED is associated with major comorbidities such as cardiovascular disease, hypertension, dyslipidaemia, psychological conditions and diabetes mellitus. Thus, appropriately identifying this medical condition may lead prompt diagnoses and treatment of other major diseases.
Collapse
Affiliation(s)
- Nobutaka Hirooka
- University of Pittsburgh Family Medicine, Faculty Development Fellowship (UPMC Shadyside), Pittsburgh, Pennsylvania, USA.
| | | |
Collapse
|
40
|
Karavitakis M, Komninos C, Theodorakis PN, Politis V, Lefakis G, Mitsios K, Koritsiadis S, Doumanis G. Evaluation of Sexual Function in Hypertensive Men Receiving Treatment: A Review of Current Guidelines Recommendation. J Sex Med 2011; 8:2405-14. [DOI: 10.1111/j.1743-6109.2011.02342.x] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
41
|
Amano T, Imao T, Seki M, Takemae K, Ohta Y, Sakai S, Ohta H. The usefulness of vibration perception threshold as a significant indicator for erectile dysfunction in patients with diabetes mellitus at a primary diabetes mellitus clinic. Urol Int 2011; 87:336-40. [PMID: 21876320 DOI: 10.1159/000327991] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2010] [Accepted: 04/01/2011] [Indexed: 11/19/2022]
Abstract
INTRODUCTION The aim of this study is to clarify the relationship of erectile dysfunction (ED) and diabetes mellitus (DM) parameters (referred to with '1'), including peripheral neuropathy (referred to with '2'). METHODS (1) The DM parameters including age, serum levels of blood sugar, hemoglobin A1c, duration of DM and number of DM complications were obtained from 145 patients at a general DM clinic. (2) The peripheral neuropathy examinations by vibration perception threshold (VPT) and Achilles tendon reflex were performed in 97 DM patients. Erectile functions in DM patients were evaluated by the International Index of Erectile Function (IIEF 5). The DM patients' parameters were compared with the IIEF 5 scores. RESULTS (1) The data showed IIEF 5 scores were significantly correlated with patient age, duration of DM and number of DM complications. (2) IIEF 5 scores were significantly correlated with VPT time. Furthermore, multiple regression analysis revealed that patient age and VPT time were independent risk factors for predicting ED in DM patients. CONCLUSIONS The severity of ED in DM patients depended on age, duration of DM, number of DM complications and VPT. Significantly, the age of DM patients and the measurement of VPT are considered to be simple and useful indicators to diagnose ED in DM patients.
Collapse
Affiliation(s)
- Toshiyasu Amano
- Department of Urology, Nagano Red Cross Hospital, Nagano, Japan. amanot @ nagano-med.jrc.or.jp
| | | | | | | | | | | | | |
Collapse
|
42
|
Chew KK, Gibson N, Sanfilippo F, Stuckey B, Bremner A. Cardiovascular Mortality in Men with Erectile Dysfunction: Increased Risk But Not Inevitable. J Sex Med 2011; 8:1761-71. [DOI: 10.1111/j.1743-6109.2011.02239.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
43
|
Ab Rahman AA, Al-Sadat N, Yun Low W. Prevalence of erectile dysfunction in primary care setting, Malaysia. JOURNAL OF MENS HEALTH 2011. [DOI: 10.1016/s1875-6867(11)60021-3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
44
|
Ab Rahman AA, Al-Sadat N, Yun Low W. Help seeking behaviour among men with erectile dysfunction in primary care setting. JOURNAL OF MENS HEALTH 2011. [DOI: 10.1016/s1875-6867(11)60033-x] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
45
|
Yang G, Pan C, Lu J. Prevalence of erectile dysfunction among Chinese men with type 2 diabetes mellitus. Int J Impot Res 2010; 22:310-7. [PMID: 20811390 DOI: 10.1038/ijir.2010.21] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
The aims of this study were to investigate the prevalence of ED in Chinese men with type 2 diabetes mellitus, and evaluate the efficacy and safety of sildenafil citrate in these patients. Patients from 42 outpatient diabetes clinics with type 2 diabetes mellitus and ED as defined by the International Index of Erectile Function (IIEF)-5 were studied. Participants with ED received three doses (100 mg each) of sildenafil citrate for use over 3 months. Efficacy of sildenafil citrate was assessed using the IIEF-5 and the Global Efficacy Questionnaire (GEQ). Adverse events were recorded by patients in a daily diary. A total of 5477 participants were evaluated, and 75.2% had ED. Age, duration of diabetes and glycosylated hemoglobin (HbA(1)c) >6.5% were independently and significantly associated with the presence and degree of ED. Patients who received pharmacotherapy (N=389) reported significant improvements. The rate of erections as determined by the GEQ was also significantly improved following treatment. ED is a common complication in Chinese men with type 2 diabetes mellitus, and certain risk factors are associated with the presence of ED and severity. Sildenafil citrate is a safe and effective treatment for these patients.
Collapse
Affiliation(s)
- G Yang
- Department of Endocrinology, Chinese PLA General Hospital, Beijing, China
| | | | | |
Collapse
|
46
|
Paick JS, Kim JJ, Kim SC, Moon KH, Min KS, Park K, Suh JK, Yang DY. Efficacy and Safety of Mirodenafil in Men Taking Antihypertensive Medications. J Sex Med 2010; 7:3143-52. [DOI: 10.1111/j.1743-6109.2010.01926.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
47
|
Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients. Int Urol Nephrol 2010; 43:309-14. [PMID: 20680450 DOI: 10.1007/s11255-010-9809-5] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/09/2010] [Accepted: 07/12/2010] [Indexed: 01/23/2023]
Abstract
AIM Chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) is a common disabling condition that is primarily associated with pain in the urogenital region and disturbances in urinary and sexual function. Chronic pelvic pain symptoms are the most common presentation, especially perineal, lower abdominal, testicular, penile as well as ejaculatory pain. Other genitourinary tract complaints include voiding disorders and sexual dysfunction. We aimed in the study at examining the prevalence rates of premature ejaculation and erectile dysfunction in patients with chronic pelvic pain syndrome and comparing these rates with those of healthy control subjects. MATERIALS AND METHODS Between November 2006 and January 2008, 85 patients with the diagnosis of CP/CPPS were chosen for the study; 30 patients without regular sexual activity and 12 patients without inclusion criteria were excluded from the study. A total of 43 patients were included in the study. Twenty healthy volunteers without prostatitis-like syndromes were used as a control group. The sexual function of the patients and the healthy volunteers were evaluated using Arizona Sexual Function Questionary Form and International Index of Erectile Function (IIEF). Erectile dysfunction (ED), ejaculatio precox (EP) and pain on ejaculation (PEP) were investigated as sexual dysfunction. RESULTS The mean age of the patients was 33.7 (22-48) years; the mean symptom period was 37.7 (6-120) months, while the mean age of the control group was 32.4 (24-48) years. The mean NIH-CPSI score of the patient group was 26.1 (16-34). Patient group was classified as CPPS type IIIa and CPPS type IIIb. Mild and moderate erectile dysfunction (ED) was found in [9] 23.2% patients at the patient group and [2] 10% at the control group (P: 0.185). Severe erectile dysfunction was not found in both groups. Ejaculatio Precox (EP) was found at (29) 67.4% of the patient group and [7] 40% of the control group. Pain on ejaculation (PEP) was detected in [15] 37.2% of the patient group, while none of the control group had pain on ejaculation. More than one sexual dysfunction was found in [17] 41.8% of the patient group and none of the control group. Comparing patient group versus control group, ejaculation disorders (EP and PEP) and more than one sexual dysfunction disorder were statistically significant. According to ED, there is no statistical difference between the groups (P > 0.05). CONCLUSION Sexual function disorders, especially ejaculation disorders (EP and PEP), are frequently seen in CP/CPPS patients versus normal population. Age, symptoms period, symptom score and CP/CPPS subgroups are not risk factors for sexual function disorders. Patients with the diagnosis of CP/CPPS should be evaluated for sexual function disorders.
Collapse
|
48
|
Ziaei-Rad M, Vahdaninia M, Montazeri A. Sexual dysfunctions in patients with diabetes: a study from Iran. Reprod Biol Endocrinol 2010; 8:50. [PMID: 20482781 PMCID: PMC2887879 DOI: 10.1186/1477-7827-8-50] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/23/2010] [Accepted: 05/18/2010] [Indexed: 01/23/2023] Open
Abstract
BACKGROUND Diabetes mellitus is a chronic disease that causes short and long-term complications. This study aimed to investigate the prevalence of sexual dysfunctions (SD) among diabetic patients in Iran and to examine whether glycemic control has a role in SD. METHODS A consecutive sample of diabetic women and men who were registered in the Isfahan Endocrine and Metabolism Center, Iran were studied. Sexual dysfunction was evaluated using the Female Sexual Function Index (FSFI) in women and the International Index of Erectile Function (IIEF) in men. In addition the level of glycosylated hemoglobin was assessed to classify the diabetes status in patients. RESULTS In all 200 patients (100 male and 100 female) were entered into the study. The mean age of patients was 48.6 (SD = 7.3) years and most had type 2 diabetes (91.0%). The results showed that sexual dysfunctions were widespread in both gender and 165 (82.5%) patients reported that experienced at least one sexual dysfunction. There were significant associations between sexual dysfunctions and gender and type of diabetes (P = 0.04). Women and patients with type 1 diabetes had higher rates of SD. No major differences were found between SD and age, diabetes status, duration of diabetes and hypertension. In addition, glycemic control did not show a significant association with SD in both genders. CONCLUSION The findings of this study showed that SD prevalence was high in diabetic patients of both genders and the glycemic control did not correlate with the frequency of SD in the study population. It is recommended that SD should be addressed more precisely in health care practice in Iran.
Collapse
Affiliation(s)
- Marzieh Ziaei-Rad
- Faculty of Nursing and Midwifery, Islamic Azad University, Khorasgan Branch, Isfahan, Iran
| | - Mariam Vahdaninia
- Department of Social Medicine, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
| | - Ali Montazeri
- Department of Mental Health, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
| |
Collapse
|
49
|
Cordero A, Bertomeu-MartÃnez V, Mazón P, Fácila L, Bertomeu-González V, Conthe P, González-Juanatey JR. Erectile Dysfunction in High-Risk Hypertensive Patients Treated with Beta-Blockade Agents. Cardiovasc Ther 2010; 28:15-22. [DOI: 10.1111/j.1755-5922.2009.00123.x] [Citation(s) in RCA: 66] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/01/2023] Open
|
50
|
Erectile dysfunction in a Mediterranean country: results of an epidemiological survey of a representative sample of men. Int J Impot Res 2010; 22:196-203. [PMID: 20090762 DOI: 10.1038/ijir.2009.65] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/23/2023]
Abstract
The purpose of this study was to determine the prevalence of ED and its health-related correlates in a nonselected population from a Mediterranean country. The abridged 5-item version of the international index of erectile function (IIEF-5) was used as a diagnostic tool. A total of 905 men aged 18 years and above from Jordan were included in the study and answered the questions about medical history, lifestyle habits and sexual behavior. A logistic regression model was used to identify significant independent risk factors for ED. In this sample the prevalence of all degrees of ED was estimated as 49.9%. In this group of men, the degree was mild in 25%, moderate in 13.5% and severe in 11.4%. The prevalence of severe ED increased from 2.7% in men in their twenties to 38.6% in their sixties and 46% in those aged 70 years and above. Age is the single most significant risk factor. Other important risk factors include lower household income, physical inactivity, obesity, smoking, diabetes mellitus hypertension and ischemic heart disease. This study provides a quantitative estimate of the prevalence and the main risk factors for ED in our region. This condition, which represents a source of distress, should be evaluated more effectively by rigorous and standardized methods, particularly as effective treatments are now available.
Collapse
|